查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1697439

脸部注射剂市场：未来预测（2025-2030）

Facial Injectable Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计 2025 年脸部注射剂市场价值将达到 183.1 亿美元，到 2030 年预计将达到 320.8 亿美元，复合年增长率为 11.87%。

随着消费者越来越关注自己的外表，脸部注射剂的需求也不断增加。在全球范围内，随着人口的很大一部分变得更容易受到各种衰老征兆的影响，脸部注射剂的需求也在上升。与老龄化相关的症状，如老年斑、皱纹、皮肤鬆弛和脸部弹性丧失，在 25 岁至 30 岁之间开始变得明显，并在 30 岁至 65 岁之间从中度到重度不等。

此外，不断增长的需求和新技术的发展正在透过主要企业的各种美容宣传活动提高人们对微创手术的认识，进一步推动市场扩张。

市场趋势：

  • 价格实惠的脸部注射剂和对美容的日益重视推动了行业增长：具有成本效益的脸部注射剂的可用性以及对美容和美容程序的日益重视正在扩大该行业。例如，24% 的成年人表示至少接受过一次整容手术。近年来，随着人们美学诉求的不断提升以及先进美容护理的便捷获取，化妆品行业蓬勃发展。技术进步进一步支持了这一趋势，确保快速恢復、最大限度降低感染风险、无需输血并降低手术成本。
  • 人们越来越偏好微创治疗：脸部注射剂等微创治疗越来越受欢迎，因为它们被认为更安全、更容易忍受且几乎不需要停机时间。注射剂的主要类型包括神经调节剂（如肉毒桿菌）和真皮填充剂（如氢氧化钙和透明质酸）。
  • 亚太地区市场快速成长：由于中国、日本和印度等国家强劲的成长前景，预计预测期内亚太地区的脸部注射剂市场将大幅成长。这一成长背后的关键因素包括都市化加快、患者意识增强以及可支配收入增加。此外，该地区人口老化可能是需求的主要驱动力。

报告中介绍的主要企业包括艾尔建（AbbVie Inc）、博士伦医疗集团（Bausch Health Companies Inc.）、华熙生物科技股份有限公司（Bloomage Biotechnology Corporation Limited）、高德美（Galderma）等。

本报告的主要优点

  • 深刻分析：获得涵盖主要地区和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
  • 可行的建议：利用洞察力进行策略决策，在动态环境中开闢新的业务流和收益。
  • 适用范围广：对于新兴企业、研究机构、顾问公司、中小企业和大型企业来说，它都是实用且具有成本效益的。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024）和预测资料（2025-2030）
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按部门和地区（国家）分類的收益成长和预测分析
  • 公司概况（策略、产品、财务资讯、主要趋势等）

脸部注射剂市场细分为：

依产品类型

  • 肉毒桿菌毒素
  • 胶原蛋白
  • 玻尿酸
  • 颗粒/聚合物填料（PPF）
  • 羟磷石灰钙
  • 聚左旋乳酸
  • 聚甲基丙烯酸甲酯
  • 其他的

按应用

  • 美丽
  • 治疗

按最终用户

  • 皮肤科和美容诊所
  • 医院
  • 研究所

按地区

  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东和非洲

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 研究范围
  • 市场区隔

第三章 商业景气

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章脸部注射剂市场（依产品类型）

  • 介绍
  • 肉毒桿菌毒素
  • 胶原蛋白
  • 玻尿酸
    • 颗粒和聚合物填料（PPF）
    • 羟磷石灰钙
    • 聚左旋乳酸
    • 聚甲基丙烯酸甲酯
  • 其他的

第五章脸部注射剂市场（按应用）

  • 介绍
  • 为了美丽
  • 治疗

第六章脸部注射剂市场（按最终用户）

  • 介绍
  • 皮肤科和美容诊所
  • 医院
  • 研究所

第七章脸部注射剂市场（按地区）

  • 介绍
  • 北美洲
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家
  • 南美洲
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家
  • 欧洲
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家
  • 中东和非洲
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家
  • 亚太地区
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家

第八章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 企业合併、协议、商业合作
  • 竞争仪錶板

第九章 公司简介

  • Allergan（AbbVie Inc）
  • Bausch Health Companies Inc.
  • Bloomage Biotechnology Corporation Limited
  • Galderma
  • Ipsen Biopharmaceuticals Inc
  • Merz Pharma
  • Prollenium Medical Technologies
  • Sanofi
  • Sinclair Pharma
  • Suneva Medical

第十章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061613726

The facial injectable market, valued at US$18.310 billion in 2025, is projected to grow at a CAGR of 11.87%, reaching US$32.083 billion in 2030.

The demand for facial injectables is rising due to consumers' increased emphasis on physical appearance. Globally, the demand for facial injectables has also increased as a large population is susceptible to various signs of aging. The age-related symptoms of dark spots, creases, and saggy skin-that is, low facial elasticity-start to surface from 25 to 30 years and range from moderate to high severity from 30 to 65 years of age.

Moreover, growing demand and new technological developments have increased awareness of minimally invasive procedures due to the various beauty campaigns initiated by leading companies, further driving the market expansion.

Market Trends:

  • Industry growth driven by affordable facial injectables and rising aesthetic awareness: The industry is expanding due to the availability of cost-effective facial injectables and a growing emphasis on aesthetic consciousness and cosmetic procedures. For example, 24% of adults have reported undergoing at least one cosmetic procedure. The cosmetics sector has flourished in recent years, fueled by heightened aesthetic appeal and the accessibility of advanced cosmetic treatments. This trend is further supported by technological advancements that ensure quick recovery, minimal risk of infection, no blood loss, and reduced procedural costs.
  • Rising preference for minimally invasive procedures: Minimally invasive treatments, such as facial injectables, are gaining popularity as they are perceived as safer, easier to tolerate, and require little to no downtime. Key types of injectables include neuromodulators, like botulinum toxin, and dermal fillers, such as calcium hydroxylapatite and hyaluronic acid.
  • Asia-Pacific's rapid market growth: The facial injectable market in the Asia-Pacific region is expected to grow significantly during the forecast period, driven by strong growth prospects in countries like China, Japan, and India. Key factors contributing to this growth include increasing urbanization, rising patient awareness, and higher disposable incomes. Additionally, the region's large aging population is likely to be a major driver of demand.

Some of the major players covered in this report include including Allergan (AbbVie Inc), Bausch Health Companies Inc., Bloomage Biotechnology Corporation Limited, and Galderma, among others:

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Facial Injectable Market is analyzed into the following segments:

By Product Type

  • Botulinum Toxin
  • Collagen
  • Hyaluronic Acid
  • Particle & Polymer Fillers (PPF)
  • Calcium Hydroxyapatite
  • Poly-l-Lactic Acid
  • Polymethylmethacrylate
  • Others

By Application

  • Aesthetics
  • Therapeutics

By End-Users

  • Dermatology & Beauty Clinics
  • Hospitals
  • Research Institutes

By Region

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. FACIAL INJECTABLE MARKET BY PRODUCT TYPE

  • 4.1. Introduction
  • 4.2. Botulinum Toxin
  • 4.3. Collagen
  • 4.4. Hyaluronic Acid
    • 4.4.1. Particle & Polymer Fillers (PPF)
    • 4.4.2. Calcium Hydroxyapatite
    • 4.4.3. Poly-l-Lactic Acid
    • 4.4.4. Polymethylmethacrylate
  • 4.5. Others

5. FACIAL INJECTABLE MARKET BY APPLICATION

  • 5.1. Introduction
  • 5.2. Aesthetics
  • 5.3. Therapeutics

6. FACIAL INJECTABLE MARKET BY END-USERS

  • 6.1. Introduction
  • 6.2. Dermatology & Beauty Clinics
  • 6.3. Hospitals
  • 6.4. Research Institutes

7. FACIAL INJECTABLE MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End-User
    • 7.2.4. By Country
      • 7.2.4.1. USA
      • 7.2.4.2. Canada
      • 7.2.4.3. Mexico
  • 7.3. South America
    • 7.3.1. By Product Type
    • 7.3.2. By Application
    • 7.3.3. By End-User
    • 7.3.4. By Country
      • 7.3.4.1. Brazil
      • 7.3.4.2. Argentina
      • 7.3.4.3. Others
  • 7.4. Europe
    • 7.4.1. By Product Type
    • 7.4.2. By Application
    • 7.4.3. By End-User
    • 7.4.4. By Country
      • 7.4.4.1. Germany
      • 7.4.4.2. France
      • 7.4.4.3. United Kingdom
      • 7.4.4.4. Italy
      • 7.4.4.5. Spain
      • 7.4.4.6. Others
  • 7.5. Middle East and Africa
    • 7.5.1. By Product Type
    • 7.5.2. By Application
    • 7.5.3. By End-User
    • 7.5.4. By Country
      • 7.5.4.1. UAE
      • 7.5.4.2. Saudi Arabia
      • 7.5.4.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. By Product Type
    • 7.6.2. By Application
    • 7.6.3. By End-User
    • 7.6.4. By Country
      • 7.6.4.1. China
      • 7.6.4.2. Japan
      • 7.6.4.3. South Korea
      • 7.6.4.4. India
      • 7.6.4.5. Thailand
      • 7.6.4.6. Indonesia
      • 7.6.4.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Allergan (AbbVie Inc)
  • 9.2. Bausch Health Companies Inc.
  • 9.3. Bloomage Biotechnology Corporation Limited
  • 9.4. Galderma
  • 9.5. Ipsen Biopharmaceuticals Inc
  • 9.6. Merz Pharma
  • 9.7. Prollenium Medical Technologies
  • 9.8. Sanofi
  • 9.9. Sinclair Pharma
  • 9.10. Suneva Medical

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key benefits for the stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations